Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lobb

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Nature Communications|April 19, 2012
Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cellsRoberto Rangel, Liliana Guzman-Rojas, Lucia G le Roux, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2004
Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical propertiesR B Pepinsky, W-C Lee, M Cornebise, et al.
Journal of Medicinal Chemistry|March 12, 1999
Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responsesK c Lin, H S Ateeq, S H Hsiung, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
An assessment of the mechanistic differences between two integrin alpha 4 beta 1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitisD R Leone, K Giza, A Gill, et al.
The American Journal of Pathology|January 4, 2007
Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouseKyungmin Hahm, Matvey E Lukashev, Yi Luo, et al.
Cancer|April 3, 2015
Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man studyRenata Pasqualini, Randall E Millikan, Dawn R Christianson, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Nature Communications|April 19, 2012
Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cellsRoberto Rangel, Liliana Guzman-Rojas, Lucia G le Roux, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2004
Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical propertiesR B Pepinsky, W-C Lee, M Cornebise, et al.
Journal of Medicinal Chemistry|March 12, 1999
Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responsesK c Lin, H S Ateeq, S H Hsiung, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
An assessment of the mechanistic differences between two integrin alpha 4 beta 1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitisD R Leone, K Giza, A Gill, et al.
The American Journal of Pathology|January 4, 2007
Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouseKyungmin Hahm, Matvey E Lukashev, Yi Luo, et al.
Cancer|April 3, 2015
Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man studyRenata Pasqualini, Randall E Millikan, Dawn R Christianson, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Pageof 14